CatalystMarker
← board

OWPC

distress 6/10 · elevated risk
$0.00-25%today-100% from 52w high
oneworldproducts.com2 employeesFounded 2018Las Vegas, NVDrug Manufacturers - Specialty & Generic
Revenue
pre-revenue
Liquidity
$0M
Runway
0.0 yrs
Shares 1y
+9%

Price & events

-97.4% over 6M
$0.00$0.01$0.01Jan 26Apr 26Jul 264.1M
CatalystRating changeDilutionFinancingdashed = today
-25.0%
1D
-94.1%
1W
-92.7%
1M
-95.5%
3M
-97.4%
6M
-98.8%
1Y
-99.2%
2Y
-99.9%
5Y
-99.7%
All

Overview

Market Cap
$36.03K
Volume
1.70K
52 Week Range
$0.00 – $0.07
Total Shares
120.11M
Float Shares
60.03M
% Held by Insiders
38.69%
% Held by Institutions
0.00%
RVOL
0.00x

Pipeline · 0 trials · 0 upcoming

ReadoutPhaseDrugIndicationEnrollStatus
No pipeline trials tracked.

Catalyst news & presentations · 1

Approved drugs (0)

  • none — clinical-stage

Capital structure — dilution & financing

Shares out: 120,108,774 · 0 offerings/1y · 0 PIPEs
  • 2025-07-158-Kprivate_placement
  • 2025-06-308-Kmaterial_agreement
  • 2025-06-108-Kmaterial_agreement
  • 2024-07-058-Kprivate_placement
🔒 Positioning — Pro
Short interest / days-to-cover, insider buys & sells.
Upgrade to Pro
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to Pro

Wall St ratings

no consensus
  • no recent rating changes

Competitors

  • none identified

Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.